These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35155871)

  • 1. The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia.
    Kassianides X; Hazara AM; Macdougall IC; Kalra PA; Bhandari S
    Kidney Int Rep; 2022 Feb; 7(2):322-326. PubMed ID: 35155871
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of ferric derisomaltose as a treatment for anemia.
    Kassianides X; Bodington R; Bhandari S
    Expert Rev Hematol; 2021 Jan; 14(1):7-29. PubMed ID: 33317356
    [No Abstract]   [Full Text] [Related]  

  • 3. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A; Bhandari S
    Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of neutrophil gelatin-related lipid delivery protein in evaluation of renal function, nutrition, anemia and inflammation in patients with CKD.
    Gu Z; Huang Y; Yang F; Tang S; Sun J; Chen T; Liu F; Wu H; Wang J
    Nephrol Ther; 2021 Feb; 17(1):35-41. PubMed ID: 33468440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients.
    Yegenaga I; Kamis F; Baydemir C; Erdem E; Celebi K; Eren N; Baykara N
    Ann Clin Biochem; 2018 Mar; 55(2):190-197. PubMed ID: 28142264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure.
    Ambrosy AP; von Haehling S; Kalra PR; Court E; Bhandari S; McDonagh T; Cleland JGF
    Am J Cardiol; 2021 Aug; 152():138-145. PubMed ID: 34162484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
    Bhandari S; Kalra PA; Berkowitz M; Belo D; Thomsen LL; Wolf M
    Nephrol Dial Transplant; 2021 Jan; 36(1):111-120. PubMed ID: 32049331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.
    Emrich IE; Lizzi F; Siegel JD; Seiler-Mussler S; Ukena C; Kaddu-Mulindwa D; D'Amelio R; Wagenpfeil S; Brandenburg VM; Böhm M; Fliser D; Heine GH
    BMC Med; 2020 Jul; 18(1):178. PubMed ID: 32654663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
    Wolf M; Rubin J; Achebe M; Econs MJ; Peacock M; Imel EA; Thomsen LL; Carpenter TO; Weber T; Brandenburg V; Zoller H
    JAMA; 2020 Feb; 323(5):432-443. PubMed ID: 32016310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
    Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Meier Y; Larroque S; Roger SD;
    BMC Nephrol; 2017 Jan; 18(1):24. PubMed ID: 28095881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status.
    Bhandari S; Allgar V; Lamplugh A; Macdougall I; Kalra PA
    BMC Nephrol; 2021 Mar; 22(1):115. PubMed ID: 33784968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased NGAL level associated with iron store in chronic kidney disease with anemia.
    Xiang D; Wang X; Liu P; Pan Y; Zhang Q; Chi X; Jing Y; Duan X; Wei Q; Wang J; Li M; Wang C
    Clin Exp Med; 2018 Nov; 18(4):563-568. PubMed ID: 29909502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*.
    Ricci Z; Netto R; Garisto C; Iacoella C; Favia I; Cogo P
    Pediatr Crit Care Med; 2012 Nov; 13(6):667-70. PubMed ID: 22895007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney injury in infants and children with iron-deficiency anemia before and after iron treatment.
    Hassan RH; Kandil SM; Zeid MS; Zaki ME; Fouda AE
    Hematology; 2017 Oct; 22(9):565-570. PubMed ID: 28506129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of plasma and urine neutrophil gelatinase-associated lipocalin, cystatin C, and creatinine for acute kidney injury in burn patients: A prospective cohort study.
    Kim Y; Cho YS; Kym D; Yoon J; Yim H; Hur J; Chun W
    PLoS One; 2018; 13(6):e0199600. PubMed ID: 29944687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel renal markers for the assessment of renal integrity in patients undergoing knee arthroplasty - a pilot study.
    Piirainen A; Huopio J; Kokki H; Holopainen A; Pajunen T; Pulkki K; Kokki M
    J Exp Orthop; 2018 Sep; 5(1):40. PubMed ID: 30255343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.
    Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia.
    Pollock RF; Biggar P
    Expert Rev Hematol; 2020 Feb; 13(2):187-195. PubMed ID: 31928094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.